JPRN-UMIN000031157已完成未知
ong-term effects of ipragliflozin on diabetic nephropathy and blood pressure in patients with type 2 diabetes - Long-term effects of ipragliflozin on diabetic nephropathy and blood pressure in patients with type 2 diabetes
Ogawa Red Cross Hospital0 个研究点目标入组 50 人开始时间: 2018年2月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who have history or current serious diabetic complication. 2. Patients that insulin dependence is suspected. 3. Patients who have history or current cardiac failure (New York Heart Association Class III or IV), myocardial infarction or cerebrovascular disorder. 4. Patients whose eGFR lower than 45 mL/min/1.73m2, serum creatinine higher than 1.5 mg/dL. 5. Patients who have hepatic dysfunction.
研究者
相似试验
已完成
不适用
Efficacy of ipragliflozin on diabetic nephropathy in patients with type 2 diabetesType 2 diabetes with/without diabetic nephropathyJPRN-UMIN000022615Ogawa Red Cross Hospital50
已完成
不适用
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45
尚未招募
4 期
Assessment of Empagliflozin effects in coronary artery diseaseIRCT20190412043247N2Zanjan University of Medical Sciences100
尚未招募
不适用
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liverJPRN-UMIN000026549Kagawa prefectural central hospital25
招募中
不适用
Efficacy of Ipragliflozin in type 1 diabetic patientstype 1 diabetic patientsJPRN-UMIN000036038Ise Red Cross Hospital Department of Metabolic Diseases50